A closer look at “Three-Parent IVF: Promised Cure for Mitochondrial Disease Faces Scrutiny in New Studies”, exactly as the source publishes it. The groundbreaking 'three-parent IVF' technique, pioneered by researchers at the UK’s Newcastle Fertility Centre and first used clinically in 2015, was hailed as a breakthrough for preventing devastating mitochondrial diseases passed from mother to child. The procedure, which involves combining nucl The procedure, which involves combining nuclear DNA from the intended parents with healthy mitochondria from a donor egg, has been approved in the UK and used in over 40 cases.
However, recent studies published in Nature and The Lancet reveal concerning findings: residual mutant mitochondria can persist in some embryos, potentially leading to disease onset later in life. Sarah Chan of Edinburgh University warn that long-term monitoring is essential, as the technology may not offer the guaranteed protection once believed. This listing links straight to the original page, where the content is available in full.